Increased risk of Lupus, Scleroderma, and other Autoimmune-Related Diseases following COVID-19 Infection

April 1, 2022

The American Academy of Dermatology 2022 Annual Meeting was held last weekend. A session presented by Brigham and Women’s Hospital clinical fellow of medicine Zachary Holcomb, MD showed that their research findings demonstrated a “signal triggering various autoimmune disease risks” following COVID-19 infection. Holcomb went on to state, “now we’re seeing some of the more long-term sequelae. I think we’re going to have more and more data that comes out over the years of the rate of these autoimmune diseases and long-term health implications of things like long COVID and development of additional systemic and autoimmune processes.” Specific diseases mentioned included dermatomyositis, scleroderma, lupus, and psoriasis.

For more information, watch the interview here.





Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.